189 related articles for article (PubMed ID: 36523511)
21. A neutrophil extracellular traps-associated lncRNA signature predicts the clinical outcomes in patients with lung adenocarcinoma.
Ding W; Li B; Zhang Y; He L; Su J
Front Genet; 2022; 13():1047231. PubMed ID: 36419832
[No Abstract] [Full Text] [Related]
22. Identification and validation of molecular subtypes and prognostic signature for stage I and stage II gastric cancer based on neutrophil extracellular traps.
Mu L; Qiu G
Open Med (Wars); 2024; 19(1):20230860. PubMed ID: 38221932
[TBL] [Abstract][Full Text] [Related]
23. Identification and Validation of Molecular Subtype and Prognostic Signature for Bladder Cancer Based on Neutrophil Extracellular Traps.
Tu Y; Mao Z
Cancer Invest; 2023 Apr; 41(4):354-368. PubMed ID: 36762827
[TBL] [Abstract][Full Text] [Related]
24. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
Yang H; Han M; Li H
Front Oncol; 2020; 10():707. PubMed ID: 32432045
[No Abstract] [Full Text] [Related]
25. Integrating bioinformatic analysis and detailed experiments reveal an EMT-related biomarker for clear cell renal cell carcinoma.
Ge Y; Ma S; Zhang J; Xiong Z; Li B; Ma S; Liu B; Yao X; Wang Z
Cancer Med; 2023 Sep; 12(18):19320-19336. PubMed ID: 37676078
[TBL] [Abstract][Full Text] [Related]
26. Development and Validation of a Nine-Redox-Related Long Noncoding RNA Signature in Renal Clear Cell Carcinoma.
Qi-Dong X; Yang X; Lu JL; Liu CQ; Sun JX; Li C; Wang SG
Oxid Med Cell Longev; 2020; 2020():6634247. PubMed ID: 33425212
[TBL] [Abstract][Full Text] [Related]
27. A new CCCH-type zinc finger-related lncRNA signature predicts the prognosis of clear cell renal cell carcinoma patients.
Shen C; Chen Z; Jiang J; Zhang Y; Xu W; Peng R; Zuo W; Jiang Q; Fan Y; Fang X; Zheng B
Front Genet; 2022; 13():1034567. PubMed ID: 36246657
[No Abstract] [Full Text] [Related]
28. Integrative analysis of the SOX family-related prognostic signature and immunological infiltration in prostate cancer.
Li Z; Wang F
Transl Cancer Res; 2023 Aug; 12(8):2048-2062. PubMed ID: 37701109
[TBL] [Abstract][Full Text] [Related]
29. Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma.
Dong Y; Ma WM; Yang W; Hao L; Zhang SQ; Fang K; Hu CH; Zhang QJ; Shi ZD; Zhang WD; Fan T; Xia T; Han CH
BMC Cancer; 2021 Oct; 21(1):1135. PubMed ID: 34688260
[TBL] [Abstract][Full Text] [Related]
30. Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma.
Ma W; Zhong M; Liu X
Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34402862
[TBL] [Abstract][Full Text] [Related]
31. Identification of a combined lncRNA prognostic signature and knockdown of lncRNA MANCR to inhibit progression of clear cell renal cell carcinoma by bioinformatics analysis.
Xue S; Guo H; Wei S; Song Y; Huang J; Deng S; Li Q; Li W
Transl Androl Urol; 2022 Sep; 11(9):1304-1317. PubMed ID: 36217399
[TBL] [Abstract][Full Text] [Related]
32. Construction and validation of a ferroptosis-related long noncoding RNA signature in clear cell renal cell carcinoma.
Zhu Z; Zhang C; Qian J; Feng N; Zhu W; Wang Y; Gong Y; Li X; Lin J; Zhou L
Cancer Cell Int; 2022 Sep; 22(1):283. PubMed ID: 36104748
[TBL] [Abstract][Full Text] [Related]
33. A Bioinformatic Analysis of Immune-Related Prognostic Genes in Clear Cell Renal Cell Carcinoma Based on TCGA and GEO Databases.
Li J; Cao J; Li P; Deng R; Yao Z; Ying L; Tian J
Int J Gen Med; 2022; 15():325-342. PubMed ID: 35035230
[TBL] [Abstract][Full Text] [Related]
34. Angiogenesis-Related Molecular Subtypes and a Novel Prognostic Signature in Clear Cell Renal Cell Carcinoma Patients.
Li H; Chen L; Ke ZB; Chen SH; Xue XY; Zheng QS; Wei Y; Zeng K; Xu N
Int J Gen Med; 2021; 14():6325-6342. PubMed ID: 34629897
[TBL] [Abstract][Full Text] [Related]
35. A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma.
Jiang W; Guo Q; Wang C; Zhu Y
Cancer Cell Int; 2019; 19():208. PubMed ID: 31404170
[TBL] [Abstract][Full Text] [Related]
36. Identification of KIF23 as a Prognostic Biomarker Associated With Progression of Clear Cell Renal Cell Carcinoma.
Wu Z; Song Y; Wu Y; Ge L; Liu Z; Du T; Zhang S; Ma L
Front Cell Dev Biol; 2022; 10():839821. PubMed ID: 35478956
[TBL] [Abstract][Full Text] [Related]
37. Construction of a 13-Gene Signature as a Novel Prognostic Marker for Patients with Clear Cell Renal Cell Carcinoma and the Role of XCR1 in Cell Proliferation.
Yuan B; Li F; Li Y; Chen Y
Cancer Manag Res; 2020; 12():4017-4027. PubMed ID: 33116819
[TBL] [Abstract][Full Text] [Related]
38. Identification of Epithelial-Mesenchymal Transition-Related lncRNA With Prognosis and Molecular Subtypes in Clear Cell Renal Cell Carcinoma.
Zhong W; Zhang F; Huang C; Lin Y; Huang J
Front Oncol; 2020; 10():591254. PubMed ID: 33324563
[TBL] [Abstract][Full Text] [Related]
39. A New Prognostic Risk Signature of Eight Ferroptosis-Related Genes in the Clear Cell Renal Cell Carcinoma.
Chen J; Zhan Y; Zhang R; Chen B; Huang J; Li C; Zhang W; Wang Y; Gao Y; Zheng J; Li Y
Front Oncol; 2021; 11():700084. PubMed ID: 34249761
[TBL] [Abstract][Full Text] [Related]
40. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.
Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y
BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
